NTRA Natera Inc

Price (delayed)

$85.28

Market cap

$10.3B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.78

Enterprise value

$10.09B

Naterais a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a ...

Highlights
Natera's gross profit has increased by 35% YoY and by 17% QoQ
NTRA's revenue is up by 32% year-on-year and by 9% since the previous quarter
The quick ratio has declined by 8% since the previous quarter but it has increased by 2.4% year-on-year
NTRA's equity is up by 8% year-on-year but it is down by 2.5% since the previous quarter

Key stats

What are the main financial stats of NTRA
Market
Shares outstanding
120.76M
Market cap
$10.3B
Enterprise value
$10.09B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
13.39
Price to sales (P/S)
9.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.32
Earnings
Revenue
$1.08B
EBIT
-$421.89M
EBITDA
-$383.28M
Free cash flow
-$286.15M
Per share
EPS
-$3.78
Free cash flow per share
-$2.49
Book value per share
$6.37
Revenue per share
$9.41
TBVPS
$12.54
Balance sheet
Total assets
$1.44B
Total liabilities
$676.37M
Debt
$430.37M
Equity
$765.33M
Working capital
$951.28M
Liquidity
Debt to equity
0.56
Current ratio
4.1
Quick ratio
3.77
Net debt/EBITDA
0.55
Margins
EBITDA margin
-35.4%
Gross margin
45.5%
Net margin
-40.2%
Operating margin
-41.2%
Efficiency
Return on assets
-31.9%
Return on equity
-62.2%
Return on invested capital
-43%
Return on capital employed
-37.2%
Return on sales
-39%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NTRA stock price

How has the Natera stock price performed over time
Intraday
-2.29%
1 week
-9.73%
1 month
-6.55%
1 year
60.51%
YTD
36.14%
QTD
-6.76%

Financial performance

How have Natera's revenue and profit performed over time
Revenue
$1.08B
Gross profit
$492.74M
Operating income
-$446.25M
Net income
-$434.8M
Gross margin
45.5%
Net margin
-40.2%
The company's net margin rose by 40% YoY and by 20% QoQ
NTRA's operating margin is up by 38% year-on-year and by 19% since the previous quarter
Natera's gross profit has increased by 35% YoY and by 17% QoQ
NTRA's revenue is up by 32% year-on-year and by 9% since the previous quarter

Growth

What is Natera's growth rate over time

Valuation

What is Natera stock price valuation
P/E
N/A
P/B
13.39
P/S
9.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.32
The EPS has increased by 32% YoY and by 16% from the previous quarter
The stock's P/B is 52% more than its last 4 quarters average of 8.8
NTRA's equity is up by 8% year-on-year but it is down by 2.5% since the previous quarter
NTRA's price to sales (P/S) is 46% higher than its last 4 quarters average of 6.2 but 12% lower than its 5-year quarterly average of 10.3
NTRA's revenue is up by 32% year-on-year and by 9% since the previous quarter

Efficiency

How efficient is Natera business performance
The ROE has grown by 42% YoY and by 15% from the previous quarter
The ROS has increased by 40% YoY and by 21% from the previous quarter
The ROA is up by 33% year-on-year and by 14% since the previous quarter
The return on invested capital has increased by 12% year-on-year and by 10% since the previous quarter

Dividends

What is NTRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NTRA.

Financial health

How did Natera financials performed over time
NTRA's total assets is 113% higher than its total liabilities
The quick ratio has declined by 8% since the previous quarter but it has increased by 2.4% year-on-year
The current ratio is down by 6% since the previous quarter but it is up by 5% year-on-year
The company's debt is 44% lower than its equity
The debt to equity has contracted by 10% YoY
NTRA's equity is up by 8% year-on-year but it is down by 2.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.